Healthcare Management

Search documents
Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance
Prnewswire· 2025-08-12 10:45
Core Viewpoint - Cardinal Health has announced the acquisition of Solaris Health, a leading urology management services organization, to enhance its multi-specialty growth strategy and expand its Urology Alliance [1][2][5]. Company Overview - Cardinal Health will provide approximately $1.9 billion in cash for the acquisition and will own about 75% of The Specialty Alliance post-acquisition [3]. - Solaris Health supports over 750 providers across more than 250 practice locations in 14 states, enhancing Cardinal Health's reach in local communities [4][11]. - The acquisition is expected to be slightly accretive to Cardinal Health's non-GAAP earnings per share in the first 12 months following the close [6]. Strategic Importance - The acquisition aligns with Cardinal Health's focus on accelerating specialty growth, particularly in urology, which is viewed as an attractive specialty [5][7]. - The combined capabilities of The Specialty Alliance and Solaris Health will empower physicians to focus on patient care, improving outcomes through integrated and coordinated care [5][6]. Financial Aspects - Cardinal Health plans to finance the acquisition through a combination of cash on hand and new debt financing, while maintaining a disciplined capital allocation framework [7][8]. - The company expects to remain within its targeted leverage range by the end of fiscal 2026 despite the acquisition [8]. Leadership Transition - Following the acquisition, Dr. Gary Kirsh, CEO of Solaris Health, will retire from his role and serve as a Senior Advisor to Cardinal Health [5][6].
Behavioral Segment Concerns Overshadow Universal Health Q2 Earnings Beat
Benzinga· 2025-07-29 18:28
Core Insights - Universal Health Services Inc. reported second-quarter adjusted earnings of $5.35 per share, exceeding the consensus estimate of $4.92 [1] - The company generated sales of $4.28 billion, reflecting a year-over-year increase of 9.6%, surpassing the consensus estimate of $4.24 billion [1] Acute Care Hospitals - Adjusted admissions at acute care hospitals increased by 2.0%, while adjusted patient days rose by 1.1% year over year [2] - Net revenue per adjusted admission increased by 3.8%, and net revenue per adjusted patient day increased by 4.7% [2] - Net revenues from acute care services increased by 7.9% on a same facility basis [3] Behavioral Health Care Facilities - Adjusted admissions at behavioral health care facilities increased by 0.4%, and adjusted patient days increased by 1.2% [4] - Net revenue per adjusted admission rose by 8.6%, while net revenue per adjusted patient day increased by 7.8% [4] - Net revenues from behavioral health care services increased by 8.9% on a same facility basis [4] Company Operations - Universal Health operates 29 inpatient acute care hospitals and 338 inpatient behavioral health facilities, along with 61 outpatient facilities [5] Guidance - The company raised its fiscal year 2025 adjusted earnings guidance to $20.00-$21.00 per share, compared to the previous range of $18.45-$19.95 [6] - Sales guidance for 2025 was narrowed to $17.09 billion-$17.31 billion, against the previous range of $17.02 billion-$17.36 billion [6] - The forecasted adjusted EBITDA for 2025 was revised to approximately $2.46 billion-$2.543 billion, up from the prior range of $2.36 billion-$2.48 billion [6] Analyst Insights - Guggenheim Partners noted that adjusted EBITDA-NCI of $643 million exceeded the consensus estimate of $615 million, but core performance was weaker than expected due to adjustments [7] - Analyst Jason Cassorla indicated that higher 2025 EBITDA could lead to increased share repurchase, with a leverage ratio of 1.9x providing flexibility for returns [8] - Despite a recent ~15% drop in stock price, UHS is trading at historically low valuation levels, with cautious investor sentiment regarding future growth in the behavioral health segment [9]
Nutex Health Responds to Short Seller Report
Prnewswire· 2025-07-24 00:32
Core Viewpoint - Nutex Health Inc. responds to allegations from a short seller report questioning its collection process, asserting that the claims are misleading and without merit [2][3]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments across 11 states, focusing on primary care and risk-bearing physician networks [1][4]. - The company was founded in 2011 and is headquartered in Houston, Texas, operating through two divisions: Hospital Division and Population Health Management Division [4][5]. Allegations and Response - The company is aware of a short seller report that challenges its medical claims collection process, which it believes misrepresents its business practices [2][3]. - Nutex Health has established a robust internal process for coding, billing, and submitting eligible medical claims, which includes a federally mandated negotiation period before independent dispute resolution [2]. Future Updates - The company plans to provide further updates regarding the allegations in its upcoming earnings release and Form 10-Q for the second quarter of 2025, expected by August 14, 2025 [3].